Effect of flunixin meglumine on prostacyclin accumulation in the equine eye.

This research studied the effects of a certain drug, flunixin meglumine, on the accumulation of prostacyclin in the eyes of horses. The researchers found that this drug lessened the accumulation of the inactive metabolite of prostacyclin.

Objective and Methodology of the Study

• The goal of this research was to study and understand the presence of prostacyclin in the aqueous humor of horses, the increase in prostacyclin following a procedure called anterior chamber paracentesis, and the impact of the drug flunixin meglumine on this accumulation.
• Twenty healthy ponies were selected and put under general anesthesia for the study.
• The procedure of anterior chamber paracentesis, which involves removing fluid from the chamber at the front of the eye, was performed on both eyes of the ponies. Immediately after this, 25mg of flunixin meglumine was administered in the left eye via a subconjunctival injection.
• 1.5 hours post the administration of the drug, the procedure of aqueous paracentesis was conducted again on both eyes to collect fluid samples.

Data Collection and Analysis

• The samples collected were assayed for the presence of 6-keto PGF1alpha which is a stable, inactive metabolite of prostacyclin.
• The collected data was analyzed to understand the effect of flunixin meglumine on the accumulation of prostacyclin in the eyes.

Results and Conclusion

• The conclusion drawn from the study was that the eyes, where the drug had been administered, had lesser quantities of 6-keto PGF1alpha compared to the control eyes. Thus, indicating that flunixin meglumine reduces the accumulation of the inactive metabolite of prostacyclin in the equine eye.
• This finding provides valuable insights into the potential effects of flunixin meglumine on equine eye physiology and has implications for equine eye health and treatment strategies.